|Articles|May 1, 2005
- Pharmaceutical Executive-05-01-2005
- Volume 0
- Issue 0
TOC
TOC
Advertisement
Articles in this issue
over 20 years ago
Pharm Exec Ad Starsover 20 years ago
Elephant or Specialist?over 20 years ago
Global Report: Iron Fistover 20 years ago
Washington Report: The Pendulum Swingsover 20 years ago
What Does It Take to be a Global Leader in Trainingover 20 years ago
Unleash the Tabletsover 20 years ago
Eisai's New Leadershipover 20 years ago
Superstar Selectionover 20 years ago
TOCover 20 years ago
Professional Persuasion:101Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
From Advantage to Essential: How Daily Data & AI Alerts Transform Commercial Functions
4
Navigating the Complexities of a Global Pharma Expansion
5
